FDA Inspection
Actavis Laboratories UT, Inc.Actavis Laboratories UT, Inc. – FDA Inspection, Sep 19, 2025
Record Details
This FDA Inspection record concerns Actavis Laboratories UT, Inc., with an inspection on September 19, 2025, issued by the Denver District Office, covering human drugs.
View Company Profile
ID · 551c111b-91a0-4aa0-a48c-8f38beb28459
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1282698
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Actavis Laboratories UT, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 19, 2024 | OAI | Drug Quality Assurance | |
| August 20, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 25, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | Not classified | Denver District Office |
Other documents for Actavis Laboratories UT, Inc.
- FDA Inspection 1230375 - 2024-03-19
- FDA Inspection 1149636 - 2021-08-20
- FDA Inspection 1065736 - 2018-08-02
- FDA Inspection 1035181 - 2017-10-25
- FDA Inspection 1012979 - 2017-05-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.